Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05908565 · ClinicalTrials.gov registry record · NA
Project 2: Optimizing Engagement and Outcomes in STAND Digital Therapy
A NA study of Depression and Anxiety, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- NA
- Development phase
- 240
- Enrollment target
- 1
- Study location
NCT05908565: Recruiting NA study of Depression and Anxiety, sponsored by University of California, Los Angeles.
NCT05908565 is a NA study of Depression and Anxiety that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 240 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05908565, a NA study of Depression and Anxiety, is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal is to optimize peer coaching in order to optimize engagement and outcomes in digital therapy. The unmet mental health needs of community college students are staggering and a growing body of research demonstrates that therapy provided digitally with the assistance of trained community members without advanced degrees in mental health is an effective and scalable way to address these needs. Despite being effective for improving symptoms and functioning in those who engage in it, uptake and engagement in digital therapy is generally quite low. Recent research suggests that this is especially true of Latinx individuals, who tend to have unique and significant unmet mental health needs. To address these issues, Project 2 will examine treatment engagement, treatment satisfaction, symptoms and functioning outcomes among Latinx students at East Los Angeles College (ELAC) receiving digital therapy with peer coaching in the STAND program.
Primary Outcome
Indexed by 1) proportion of digital therapy lessons completed and 2) proportion of coaching sessions attended.
Conditions Studied
Interventions
- BEHAVIORAL Demographic Matching
- BEHAVIORAL Supervision Intensity
Study Locations (1)
California
- East Los Angeles College - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2023-04-26 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
What NCT05908565 shows while recruiting
NCT05908565 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (69% lower).
The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Demographic Matching is the first listed.
NCT05908565 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05908565 about?
NCT05908565 is a clinical study titled "Project 2: Optimizing Engagement and Outcomes in STAND Digital Therapy". The goal is to optimize peer coaching in order to optimize engagement and outcomes in digital therapy. The unmet mental health needs of community college students are staggering and a growing body of research demonstrates that therapy provided digitally with the assistance of trained community membe...
What is the current status of trial NCT05908565?
This trial is currently recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2023-04-26. Estimated completion is 2026-04-30.
What conditions does trial NCT05908565 study?
This clinical trial studies the following conditions: Depression, Anxiety.
What interventions are being tested in trial NCT05908565?
The interventions under investigation include: Demographic Matching (BEHAVIORAL), Supervision Intensity (BEHAVIORAL).
Who is sponsoring clinical trial NCT05908565?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05908565 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05908565's enrollment target sits among peer trials
240 177th of 679 higher than 494 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy